Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
What 8 Analyst Ratings Have To Say About Insulet
06:08pm, Friday, 05'th Aug 2022 Benzinga
Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
2
3
0
0
Last 30
Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance
12:42pm, Friday, 05'th Aug 2022 Benzinga
Insulet Corporation (NASDAQ: PODD) posted a Q2 net loss of $(35) million, or an EPS loss of $(0.50) compared to $(0.37) a year ago.
Q2 sales increased 13.8% Y/Y, or 17.7% in constant currency, to $2
Insulet to Present at Upcoming Investor Conferences
06:01am, Friday, 05'th Aug 2022
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management
Insulet (PODD) Reports Q2 Loss, Tops Revenue Estimates
09:45pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Insulet (PODD) delivered earnings and revenue surprises of -128.57% and 2.84%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Insulet: Bullish Factors For Portfolio Inclusion
07:21am, Saturday, 23'rd Jul 2022
Insulet presents with compelling near-term upside capture over the coming 4-6 months. We estimate the stock to continue re-rating to the upside, based on a confluence of market, fundamental and techni
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022
03:53pm, Monday, 11'th Jul 2022 Benzinga
Upgrades
For Visteon Corp (NASDAQ:VC), Exane BNP Paribas upgraded the previous rating of Neutral to Outperform. For the first quarter, Visteon had an EPS of $1.09, compared to year-ago quarter EPS of
Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022
06:01am, Thursday, 30'th Jun 2022
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
7 Stocks to Buy That Could Make You a Millionaire
07:00am, Thursday, 23'rd Jun 2022
These seven of the best stocks to buy in June. TXG, BRKR, ETSY, PODD, MAR, RH and SEDG can make excellent investments.
3 Humbled Nasdaq Stocks Ready to Bounce Back
12:19pm, Tuesday, 14'th Jun 2022 The Motley Fool
These names are at the bottom of the bargain bin.
4 Analysts Have This to Say About Insulet
05:11pm, Tuesday, 07'th Jun 2022 Benzinga
Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
1
0
0
Last 30
Insulet (PODD) Reports Pivotal Extended Phase Data for Omnipod 5
04:52pm, Monday, 06'th Jun 2022 Zacks Investment Research
Insulet's (PODD) Omnipod 5 showed improved time in range and lower HbA1c for pre-school children during an extended phase of the previous pivotal trial.
Insulet (PODD) Reports Pivotal Extended Phase Data for Omnipod 5
02:17pm, Monday, 06'th Jun 2022
Insulet's (PODD) Omnipod 5 showed improved time in range and lower HbA1c for pre-school children during an extended phase of the previous pivotal trial.
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2022 Update
04:49am, Monday, 06'th Jun 2022 Seeking Alpha
Halvorsen's 13F portfolio value decreased from $34.49B to $24.74B this quarter. The top 3 positions are T-Mobile US, Amazon.com, and General Electric, together, at ~16% of the portfolio.
2 of the Nasdaq's Best Long-Term Buys Right Now
02:15pm, Thursday, 02'nd Jun 2022 The Motley Fool
You can buy and forget about these stocks.
Insulet (PODD) to Expand Base in Malaysia With New Facility
01:27pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
The new manufacturing facility by Insulet (PODD) is set to have approximately 400,000 square feet of manufacturing space.
